A variety of conditions decelerated Extremities Market growth, but new product introductions should accelerate future growth
Among the many topics covered in detail in our comprehensive Q222 Extremities Market Recap* are:
By Lisa Mahan on 9/15/22 9:30 AM
A variety of conditions decelerated Extremities Market growth, but new product introductions should accelerate future growth
Among the many topics covered in detail in our comprehensive Q222 Extremities Market Recap* are:
By Lisa Mahan on 6/24/22 9:27 AM
The return of elective procedure volumes, new product offerings and a busy first quarter of acquisitions all supported healthy growth for the Extremities Market
While growth drivers varied for specific companies in Q122, the return of elective procedure volumes helped drive double-digit growth for several market players. Stryker*, the Extremities Market leader, benefited from the return of elective procedures in the US. Its US Foot & Ankle and Upper Extremities business segments contributed to the Company’s US Trauma & Extremities growth during the quarter. Stryker also noted during its earnings call that ...
Among the many topics covered in detail in our comprehensive Q122 Extremities Market Recap* are:
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.
© BioMedGPS, LLC. All rights reserved.